Platinum Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Platinum Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-164,700	Closed	-$2.05M	–	80
2016 Q4	$2.05M	Hold	164,700	–	–	0.06%	45
2016 Q3	$2.25M	Sell	164,700 -85,600	-34%	-$860K	0.05%	53
2016 Q2	$1.85M	Hold	250,300	–	–	0.05%	54
2016 Q1	$1.6M	Buy	250,300 +138,000	+123%	+$773K	0.04%	58
2015 Q4	$701K	Hold	112,300	–	–	0.02%	77
2015 Q3	$655K	Hold	112,300	–	–	0.02%	73
2015 Q2	$928K	Hold	112,300	–	–	0.02%	73
2015 Q1	$925K	Hold	112,300	–	–	0.02%	80
2014 Q4	$771K	Hold	112,300	–	–	0.01%	84
2014 Q3	$606K	Hold	112,300	–	–	0.01%	87
2014 Q2	$715K	Hold	112,300	–	–	0.01%	88
2014 Q1	$905K	Hold	112,300	–	–	0.02%	79
2013 Q4	$765K	Buy	112,300 +60,000	+115%	+$324K	0.01%	76
2013 Q3	$962K	Hold	52,300	–	–	0.02%	71
2013 Q2	$914K	Buy	+52,300	New	+$927K	0.02%	64

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Platinum Investment Management's ARIA Position: Q1 2017 in Review

Platinum Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 164,700 shares — an estimated $2.05M sold.

Platinum Investment Management first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $2.25M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Platinum Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Platinum Investment Management sold 164,700 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.05M.
Platinum Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Platinum Investment Management's Ariad Pharmaceuticals Inc position peaked at $2.25M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Platinum Investment Management's 13F filing for Q1 2017, filed 16 May 2017.